{
  "title": "Paper_533",
  "abstract": "pmc BMB Rep BMB Rep 2515 bmbreps BMB Reports 1976-6696 1976-670X Korean Society for Biochemistry and Molecular Biology PMC12481284 PMC12481284.1 12481284 12481284 40754779 10.5483/BMBRep.2025-0053 bmb-58-9-389 1 Invited Mini Review Roles of RNA modifications in aging and age-related diseases Kang Eunseok # Haque Rosa # Lee Hanseul Lee Seung-Jae V. * Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea * seungjaevlee@kaist.ac.kr # These authors contributed equally to this work. 30 9 2025 7 7 2025 58 9 497977 389 396 20 3 2025 2 5 2025 27 5 2025 07 07 2025 01 10 2025 01 10 2025 Copyright © 2025 by the The Korean Society for Biochemistry and Molecular Biology 2025 https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0 RNA modifications are key epigenetic alterations that play regulatory functions in RNA biology, including RNA stability and translation. Emerging evidence indicates that RNA modification is crucial for various physiological and pathological processes, including aging. This review describes functions of key RNA modifications, including N 6 6 5 N 7 7 N 1 1 Age-related diseases Aging Longevity RNA modification Senescence National Research Foundation of Korea http://dx.doi.org/10.13039/501100003725 RS-2024-00408712 Ministry of Science and ICT, South Korea http://dx.doi.org/10.13039/501100014188 RS-2024-00408712 pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes INTRODUCTION Aging is a progressive decline in cellular and physiological functions that increases susceptibility to various diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and cardiovascular diseases, leading to vulnerability to death ( 1 2 1 3 4 5 RNA modifications are key epigenetic alterations that play important regulatory roles in RNA quality, including stability, splicing, translation, transport, and localization ( 6 7 8 9 11 In this review, we describe the roles of various RNA modifications in aging, and their association with age-related diseases. We describe key RNA modifications ( Fig. 1 N 6 6 N 6 6 7 12 6 6 13 14 6 15 9 6 6 16 17 6 N 6 18 19 μ 6 20 21 6 20 6 6 21 6 NPNT 21 22 25 6 Multiple studies have provided evidence for crucial roles of m 6 20 26 29 METTL3 6 27 METTL3 27 METTL3 MIS12 27 METTL3 METTL14 20 29 METTL14 6 LBR LBR 28 6 p21 26 28 6 Although direct roles of m 6 30 33 Mettl3 6 33 Mettl3 33 6 6 32 6 6 34 36 Mettl3 30 FTO 6 31 Fto 31 6 5-Methylcytosine (m 5 5-Methylcytosine (m 5 37 38 39 40 5 5 5 Among regulators of m 5 NSUN5 41 5 RCM1 rcm1 Caenorhabditis elegans Drosophila melanogaster 5 5 NSUN2, another m 5 26 42 45 5 p16 42 NSUN2 45 5 p21 26 5 NSUN2 43 44 5 5 5 N 7 7 N 7 7 8 7 8 7 μ 7 Drosophila 46 7 Mettl1 Drosophila METTL1/CG4045 METTL1 WDR4 METTL1 7 7 2’-O-methylation (Nm) 2’-O-methylation (Nm) is an abundant and highly conserved RNA modification, in which a methyl group is added to the ribose moiety ( 47 48 Nm is essential for stability of small RNAs, including miRNAs, which play crucial roles in aging processes ( 49 Drosophila 50 Ago2 Hen1 HENMT1 Drosophila Drosophila 51 52 52 51 N 1 1 N 1 1 53 1 1 m 1 54 56 56 TRMT10C 56 1 2 57 58 1 54 55 1 MFAP2 55 1 CSF1 54 1 CSF1 1 1 Adenosine-to-inosine editing (A-to-I editing) Adenosine-to-inosine editing (A-to-I editing) converts adenosine nucleotide to inosine within double-stranded RNAs ( 59 61 A-to-I editing is essential for gene regulation and transcriptomic diversity, and is implicated in organismal aging across species, including C. elegans 62 63 adr-2 C. elegans 63 ADAR2 ADAR3 62 C. elegans 64 C. elegans A-to-I editing is decreased in age-associated neurological disorders such as AD ( 65 66 65 66 67 Pseudouridylation (ψ) Pseudouridylation (ψ) is abundantly detected in the majority of eukaryotic RNA classes, including tRNAs, snRNAs, snoRNAs, miRNAs, and mRNAs ( 68 69 The dynamics of ψ and the ψ-modulating enzymes change during organismal aging and cellular senescence ( 64 70 C. elegans 64 C. elegans 70 DKC1 71 Dkc1 72 N4-acetylcytidine (ac4C) N4-acetylcytidine (ac4C) modification is a highly conserved RNA modification in prokaryotes and eukaryotes ( 73 74 The role of NAT10 is implicated in age-related diseases, including cancer and AD ( 75 79 76 79 76 78 75 CONCLUSIONS Here, we described various chemical modifications of RNAs, focusing on m 6 5 7 1 Fig. 2 Despite the progress on the roles of diverse RNA modifications in aging and age-related diseases, numerous questions remain unanswered. Mechanisms by which specific RNA modifications are altered during aging and their causal roles that regulate regulating organismal aging remain mostly elusive. For instance, while an age-associated increase in A-to-I editing and ψ has been reported in C. elegans 1 By expanding our understanding of RNA functions and modulation methods, RNA-based therapeutics are rapidly emerging as a promising therapeutic strategy ( 80 84 85 86 85 86 ACKNOWLEDGEMENTS This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (RS-2024-00408712) to S.J.V.L. The authors utilized ChatGPT 4o (OpenAI) to improve language clarity of the manuscript.  CONFLICTS OF INTEREST The authors have no conflicting interests. References 1 Guo J Huang X Dou L 2022 Aging and aging-related diseases: from molecular mechanisms to interventions and treatments Signal Transduct Target Ther 7 391 10.1038/s41392-022-01251-0 dbe96fe6b2ed4ef7a017b66ba6eb9f4f 36522308 PMC9755275 2 Lopez-Otin C Blasco MA Partridge L Serrano M Kroemer G 2023 Hallmarks of aging: an expanding universe Cell 186 243 278 10.1016/j.cell.2022.11.001 36599349 3 Yousefzadeh M Henpita C Vyas R Soto-Palma C Robbins P Niedernhofer L 2021 DNA damage-how and why we age? Elife 10 e62852 10.7554/eLife.62852 08d0d6ef18b145da81cb7a7b599d3f46 33512317 PMC7846274 4 Kwon HC Bae Y Lee SV 2023 The role of mRNA quality control in the aging of Caenorhabditis elegans Mol Cells 46 664 671 10.14348/molcells.2023.0103 37968980 PMC10654458 5 Lee GY Ham S Sohn J Kwon HC Lee SV 2024 Meta-analysis of the transcriptome identifies aberrant RNA processing as common feature of aging in multiple species Mol Cells 47 100047 10.1016/j.mocell.2024.100047 38508494 PMC11026732 6 Delaunay S Helm M Frye M 2024 RNA modifications in physiology and disease: towards clinical applications Nat Rev Genet 25 104 122 10.1038/s41576-023-00645-2 37714958 7 Roundtree IA Evans ME Pan T He C 2017 Dynamic RNA modifications in gene expression regulation Cell 169 1187 1200 10.1016/j.cell.2017.05.045 28622506 PMC5657247 8 Qiu L Jing Q Li Y Han J 2023 RNA modification: mechanisms and therapeutic targets Mol Biomed 4 25 10.1186/s43556-023-00139-x 5804ab15527a485d93f75cb25e710dcd 37612540 PMC10447785 9 Barbieri I Kouzarides T 2020 Role of RNA modifications in cancer Nat Rev Cancer 20 303 322 10.1038/s41568-020-0253-2 32300195 10 Zhang Y Chen W Zheng X 2021 Regulatory role and mechanism of m(6)A RNA modification in human metabolic diseases Mol Ther Oncolytics 22 52 63 10.1016/j.omto.2021.05.003 46e2fd49ef9340feae6959fba0c2aa37 34485686 PMC8399361 11 Jiapaer Z Su D Hua L 2022 Regulation and roles of RNA modifications in aging-related diseases Aging Cell 21 e13657 10.1111/acel.13657 35718942 PMC9282851 12 Jung I Kim YK 2023 Exon junction complex is a molecular compass of N(6)-methyladenosine modification Mol Cells 46 589 591 10.14348/molcells.2023.0101 37853685 PMC10590705 13 Jiang X Liu B Nie Z 2021 The role of m6A modification in the biological functions and diseases Signal Transduct Target Ther 6 74 10.1038/s41392-020-00450-x 6713afd9239d44a7ad0a9b5c9cd8e10c 33611339 PMC7897327 14 Cui L Ma R Cai J 2022 RNA modifications: importance in immune cell biology and related diseases Signal Transduct Target Ther 7 334 10.1038/s41392-022-01175-9 362c87849b544969a96dc06a26b23021 36138023 PMC9499983 15 Liu J Yue Y Han D 2014 A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation Nat Chem Biol 10 93 95 10.1038/nchembio.1432 24316715 PMC3911877 16 Jia G Fu Y Zhao X 2011 N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO Nat Chem Biol 7 885 887 10.1038/nchembio.687 22002720 PMC3218240 17 Zheng G Dahl JA Niu Y 2013 ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility Mol Cell 49 18 29 10.1016/j.molcel.2012.10.015 23177736 PMC3646334 18 Dominissini D Moshitch-Moshkovitz S Schwartz S 2012 Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq Nature 485 201 206 10.1038/nature11112 22575960 19 Huang H Weng H Sun W 2018 Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation Nat Cell Biol 20 285 295 10.1038/s41556-018-0045-z 29476152 PMC5826585 20 Min KW Zealy RW Davila S 2018 Profiling of m6A RNA modifications identified an age-associated regulation of AGO2 mRNA stability Aging Cell 17 e12753 10.1111/acel.12753 29573145 PMC5946072 21 Wu Z Lu M Liu D 2023 m(6)A epitranscriptomic regulation of tissue homeostasis during primate aging Nat Aging 3 705 721 10.1038/s43587-023-00393-2 37118553 22 Gonzalez-Gualda E Baker AG Fruk L Munoz-Espin D 2021 A guide to assessing cellular senescence in vitro and in vivo FEBS J 288 56 80 10.1111/febs.15570 32961620 23 Ryu W Park CW Kim J Lee H Chung H 2023 The Bcl-2/Bcl-xL inhibitor ABT-263 attenuates retinal degeneration by selectively inducing apoptosis in senescent retinal pigment epithelial cells Mol Cells 46 420 429 10.14348/molcells.2023.2188 37222160 PMC10336274 24 Kang E Kang C Lee YS Lee SV 2024 Brief guide to senescence assays using cultured mammalian cells Mol Cells 47 100102 10.1016/j.mocell.2024.100102 39053732 PMC11374973 25 Yan J Chen S Yi Z 2024 The role of p21 in cellular senescence and aging-related diseases Mol Cells 47 100113 10.1016/j.mocell.2024.100113 39304134 PMC11564947 26 Li Q Li X Tang H 2017 NSUN2-mediated m5C methylation and METTL3/METTL14-mediated m6A methylation cooperatively enhance p21 translation J Cell Biochem 118 2587 2598 10.1002/jcb.25957 28247949 PMC5509477 27 Wu Z Shi Y Lu M 2020 METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA Nucleic Acids Res 48 11083 11096 10.1093/nar/gkaa816 33035345 PMC7641765 28 Zhang Z Xue M Chen J 2022 METTL14 regulates intestine cellular senescence through m(6)A modification of lamin B receptor Oxid Med Cell Longev 2022 9096436 10.1155/2022/9096436 36578521 PMC9792243 29 Hwang ES Song SB 2023 Impaired autophagic flux in glucose-deprived cells: an outcome of lysosomal acidification failure exacerbated by mitophagy dysfunction Mol Cells 46 655 663 10.14348/molcells.2023.0121 37867391 PMC10654461 30 Dorn LE Lasman L Chen J 2019 The N(6)-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy Circulation 139 533 545 10.1161/CIRCULATIONAHA.118.036146 30586742 PMC6340720 31 Mathiyalagan P Adamiak M Mayourian J 2019 FTO-dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair Circulation 139 518 532 10.1161/CIRCULATIONAHA.118.033794 29997116 PMC6400591 32 Han M Liu Z Xu Y 2020 Abnormality of m6A mRNA methylation is involved in Alzheimer's disease Front Neurosci 14 98 10.3389/fnins.2020.00098 32184705 PMC7058666 33 Zhao F Xu Y Gao S 2021 METTL3-dependent RNA m(6)A dysregulation contributes to neurodegeneration in Alzheimer's disease through aberrant cell cycle events Mol Neurodegener 16 70 10.1186/s13024-021-00484-x 34593014 PMC8482683 34 Jo DH Lee SH Jeon M 2023 Activation of lysosomal function ameliorates amyloid-beta-induced tight junction disruption in the retinal pigment epithelium Mol Cells 46 675 687 10.14348/molcells.2023.0056 37968982 PMC10654459 35 Kim J Seo S Park JHY Lee KW Kim J Kim JC 2023 Ca(2＋)-permeable TRPV1 receptor mediates neuroprotective effects in a mouse model of alzheimer's disease via BDNF/CREB signaling pathway Mol Cells 46 319 328 10.14348/molcells.2023.2156 37070458 PMC10183797 36 Park K Jeon MC Lee D Kim JI Im SW 2024 Genetic and epigenetic alterations in aging and rejuvenation of human Mol Cells 47 100137 10.1016/j.mocell.2024.100137 39433213 PMC11625158 37 Agris PF 2008 Bringing order to translation: the contributions of transfer RNA anticodon-domain modifications EMBO Rep 9 629 635 10.1038/embor.2008.104 18552770 PMC2475317 38 Schaefer M Pollex T Hanna K Lyko F 2009 RNA cytosine methylation analysis by bisulfite sequencing Nucleic Acids Res 37 e12 10.1093/nar/gkn954 19059995 PMC2632927 39 Song H Zhang J Liu B 2022 Biological roles of RNA m(5)C modification and its implications in cancer immunotherapy Biomark Res 10 15 10.1186/s40364-022-00362-8 2abf04dc27024f74a6701cb11119213f 35365216 PMC8973801 40 Lu Y Yang L Feng Q 2024 RNA 5-methylcytosine modification: regulatory molecules, biological functions, and human diseases Genomics Proteomics Bioinformatics 22 qzae063 10.1093/gpbjnl/qzae063 39340806 PMC11634542 41 Schosserer M Minois N Angerer TB 2015 Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan Nat Commun 6 6158 10.1038/ncomms7158 25635753 PMC4317494 42 Zhang X Liu Z Yi J 2012 The tRNA methyltransferase NSun2 stabilizes p16INK(4) mRNA by methylating the 3'-untranslated region of p16 Nat Commun 3 712 10.1038/ncomms1692 22395603 PMC3509206 43 Tang H Fan X Xing J 2015 NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation Aging 7 1143 1158 10.18632/aging.100860 26687548 PMC4712338 44 Xing J Yi J Cai X 2015 NSun2 promotes cell growth via elevating cyclin-dependent kinase 1 translation Mol Cell Biol 35 4043 4052 10.1128/MCB.00742-15 26391950 PMC4628067 45 Cai X Hu Y Tang H 2016 RNA methyltransferase NSUN2 promotes stress-induced HUVEC senescence Oncotarget 7 19099 19110 10.18632/oncotarget.8087 26992231 PMC4991368 46 Fu Y Jiang F Zhang X 2024 Perturbation of METTL1-mediated tRNA N(7)- methylguanosine modification induces senescence and aging Nat Commun 15 5713 10.1038/s41467-024-49796-8 6954f3ef7a9d46ffbf05e940a68cedc9 38977661 PMC11231295 47 Ayadi L Galvanin A Pichot F Marchand V Motorin Y 2019 RNA ribose methylation (2'-O-methylation): occurrence, biosynthesis and biological functions Biochim Biophys Acta Gene Regul Mech 1862 253 269 10.1016/j.bbagrm.2018.11.009 30572123 48 Dimitrova DG Teysset L Carre C 2019 RNA 2'-O- methylation (nm) modification in human diseases Genes (Basel) 10 117 10.3390/genes10020117 30764532 PMC6409641 49 Kinser HE Pincus Z 2020 MicroRNAs as modulators of longevity and the aging process Hum Genet 139 291 308 10.1007/s00439-019-02046-0 31297598 PMC6954352 50 Abe M Naqvi A Hendriks GJ 2014 Impact of age-associated increase in 2'-O-methylation of miRNAs on aging and neurodegeneration in Drosophila Genes Dev 28 44 57 10.1101/gad.226654.113 24395246 PMC3894412 51 Boza-Serrano A Yang Y Paulus A Deierborg T 2018 Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD Sci Rep 8 1550 10.1038/s41598-018-19699-y 29367720 PMC5784016 52 Yang G Schmid-Siegel M Heissenberger C 2024 2'-O-ribose methylation levels of ribosomal RNA distinguish different types of growth arrest in human dermal fibroblasts J Cell Sci 137 jcs261930 10.1242/jcs.261930 38345344 PMC10911272 53 Xiong W Zhao Y Wei Z 2023 N1-methyladenosine formation, gene regulation, biological functions, and clinical relevance Molecular Therapy 31 308 330 10.1016/j.ymthe.2022.10.015 54 Woo HH Chambers SK 2019 Human ALKBH3-induced m(1)A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells Biochim Biophys Acta Gene Regul Mech 1862 35 46 10.1016/j.bbagrm.2018.10.008 30342176 55 Xue M Mi S Zhang Z 2023 MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3 Cancer Med 12 8403 8414 10.1002/cam4.5561 61a92c5830d24526ad0c57d76ba06f40 36583532 PMC10134263 56 Jorg M Plehn JE Kristen M 2024 N1-methylation of adenosine (m(1)A) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease Mol Psychiatry 29 1427 1439 10.1038/s41380-024-02421-y 38287100 PMC11189808 57 Perez Ortiz JM Swerdlow RH 2019 Mitochondrial dysfunction in Alzheimer's disease: role in pathogenesis and novel therapeutic opportunities Br J Pharmacol 176 3489 3507 10.1111/bph.14585 30675901 PMC6715612 58 Kim MJ Lee H Chanda D 2023 The role of pyruvate metabolism in mitochondrial quality control and inflammation Mol Cells 46 259 267 10.14348/molcells.2023.2128 36756776 PMC10183795 59 Nishikura K 2016 A-to-I editing of coding and non-coding RNAs by ADARs Nat Rev Mol Cell Biol 17 83 96 10.1038/nrm.2015.4 26648264 PMC4824625 60 Park MJ Jeong E Lee EJ 2023 RNA editing enzyme ADAR1 suppresses the mobility of cancer cells via ARPIN Mol Cells 46 351 359 10.14348/molcells.2023.2174 36921992 PMC10258462 61 Yuan J Xu L Bao HJ Wang JL Zhao Y Chen S 2023 Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy J Exp Clin Cancer Res 42 149 10.1186/s13046-023-02727-9 d4d0d79919b549bd85402c22eec23fff 37328893 PMC10276482 62 Sebastiani P Montano M Puca A 2009 RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans PLoS One 4 e8210 10.1371/journal.pone.0008210 fa7f218462b9403da2649f61a12fb2b8 20011587 PMC2788130 63 Ganem NS Ben-Asher N Manning AC 2019 Disruption in A-to-I editing levels affects C. elegans development more than a complete lack of editing Cell Rep 27 1244 1253.e1244 10.1016/j.celrep.2019.03.095 31018137 PMC8139731 64 Schiksnis EC Nicastro IA Pasquinelli AE 2024 Full-length direct RNA sequencing reveals extensive remodeling of RNA expression, processing and modification in aging Caenorhabditis elegans Nucleic Acids Res 52 13896 13913 10.1093/nar/gkae1064 39558169 PMC11662692 65 Khermesh K D'Erchia AM Barak M 2016 Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease RNA 22 290 302 10.1261/rna.054627.115 26655226 PMC4712678 66 Wei Q Han S Yuan K 2023 Transcriptome-wide profiling of A-to-I RNA editing by Slic-seq Nucleic Acids Res 51 e87 10.1093/nar/gkad604 37470992 PMC10484733 67 Cuddleston WH Fan X Sloofman L 2022 Spatiotemporal and genetic regulation of A-to-I editing throughout human brain development Cell Rep 41 111585 10.1016/j.celrep.2022.111585 36323256 PMC9704047 68 Ge J Yu YT 2013 RNA pseudouridylation: new insights into an old modification Trends Biochem Sci 38 210 218 10.1016/j.tibs.2013.01.002 23391857 PMC3608706 69 Penzo M Guerrieri AN Zacchini F Trere D Montanaro L 2017 RNA pseudouridylation in physiology and medicine: for better and for worse Genes (Basel) 8 301 10.3390/genes8110301 29104216 PMC5704214 70 Wang Y Zhang Z He H 2023 Aging-induced pseudouridine synthase 10 impairs hematopoietic stem cells Haematologica 108 2677 2689 10.3324/haematol.2022.282211 3022efc0db8641b09d84ce11f0ff9a83 37165848 PMC10542847 71 Knight SW Vulliamy TJ Morgan B Devriendt K Mason PJ Dokal I 2001 Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis Hum Genet 108 299 303 10.1007/s004390100494 11379875 72 Ruggero D Grisendi S Piazza F 2003 Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification Science (New York, N.Y.) 299 259 262 10.1126/science.1079447 12522253 73 Jin G Xu M Zou M Duan S 2020 The processing, gene regulation, biological functions, and clinical relevance of N4-Acetylcytidine on RNA: a systematic review Mol Ther Nucleic Acids 20 13 24 10.1016/j.omtn.2020.01.037 991abe2592ef4eb1a6522543f126e087 32171170 PMC7068197 74 Xiao B Wu S Tian Y 2024 Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferase Cell Biol Toxicol 41 17 10.1007/s10565-024-09962-6 39725720 PMC11671434 75 Ma Y Li W Fan C Wang Y Jiang H Yang W 2022 Comprehensive analysis of long non-coding RNAs N4-acetylcytidine in Alzheimer's disease mice model using high-throughput sequencing J Alzheimers Dis 90 1659 1675 10.3233/JAD-220564 36314201 76 Zheng X Wang Q Zhou Y 2022 N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA Cancer Commun (Lond) 42 1347 1366 10.1002/cac2.12363 7ee8b4338b024a0f92ee33a98827a034 36209353 PMC9759759 77 Deng M Zhang L Zheng W 2023 Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression J Exp Clin Cancer Res 42 9 10.1186/s13046-022-02586-w 6a1f9ae9a4ce4f41a6fdf429a24e1789 36609449 PMC9817303 78 Long Y Ren Y Wei Q 2023 NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression Int J Med Sci 20 1079 1090 10.7150/ijms.83828 37484809 PMC10357443 79 Xu D Huang K Chen Y Yang F Xia C Yang H 2023 Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing Front Immunol 14 1133166 10.3389/fimmu.2023.1133166 cc261a1e23bc42f6a4b378df1cfcf75a 36949954 PMC10025374 80 Zhu Y Zhu L Wang X Jin H 2022 RNA-based therapeutics: an overview and prospectus Cell Death Dis 13 644 10.1038/s41419-022-05075-2 5d38d50915d9431a8393e1cee30c8f55 35871216 PMC9308039 81 Carroll D 2023 RNA in therapeutics: CRISPR in the Clinic Mol Cells 46 4 9 10.14348/molcells.2022.0163 36482771 PMC9880604 82 Ju M Kim D Son G Han J 2023 Circular RNAs in and out of cells: therapeutic usages of circular RNAs Mol Cells 46 33 40 10.14348/molcells.2023.2170 36697235 PMC9880607 83 Kim YJ Krainer AR 2023 Antisense oligonucleotide therapeutics for cystic fibrosis: recent developments and perspectives Mol Cells 46 10 20 10.14348/molcells.2023.2172 36697233 PMC9880599 84 Son S Lee K 2023 Development of mRNA vaccines/therapeutics and their delivery system Mol Cells 46 41 47 10.14348/molcells.2023.2165 36697236 PMC9880606 85 Yankova E Blackaby W Albertella M 2021 Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia Nature 593 597 601 10.1038/s41586-021-03536-w 33902106 PMC7613134 86 Li G Ma X Sui S 2024 NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction J Exp Clin Cancer Res 43 278 10.1186/s13046-024-03200-x c1a25e44cbe048c6b87831ae7b8ce92c 39363363 PMC11451012 Fig. 1 Various chemical modifications on RNA. Shown are eight representative RNA modifications. The modified parts are highlighted with blue. m 6 N 6 5 7 N 7 1 N 1 Fig. 2 Changes of RNA modification and the associated factors during aging. (A) In cynomolgus monkeys, skeletal muscle displays age-dependent decreases in m 6 6 6 5 7 Drosophila melanogaster Caenorhabditis elegans C. elegans ",
  "metadata": {
    "Title of this paper": "NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction",
    "Journal it was published in:": "BMB Reports",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481284/"
  }
}